NexImmune, Inc. (NEXI)
NGM · Common · CUSIP 65344D109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NEXI and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
65344D109
Market Cap
Micro Cap · $44 Million
IPO
2/12/2021 · $17.00/share
Business: NexImmune, based in Gaithersburg, Maryland, is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s own T cells to generate a specific, potent and durable immune response that mimics natural biology.

Company Contact

CEO
Scott Carmer
CFO
John Trainer
Headquarters
9119 Gaither Road, Gaithersburg, MD 20877
Phone
301-825-9810
Investor Relations
Chad Rubin, Solebury Trout · 646-378-2947 · crubin@soleburytrout.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »